Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.17 - $0.26 $2,501 - $3,825
-14,712 Reduced 6.97%
196,509 $36,000
Q2 2022

Aug 11, 2022

SELL
$0.2 - $0.61 $349 - $1,064
-1,745 Reduced 0.82%
211,221 $47,000
Q1 2022

May 12, 2022

BUY
$0.48 - $0.74 $4,403 - $6,788
9,174 Added 4.5%
212,966 $135,000
Q4 2021

Feb 11, 2022

BUY
$0.7 - $1.94 $12,780 - $35,420
18,258 Added 9.84%
203,792 $149,000
Q3 2021

Nov 12, 2021

SELL
$1.82 - $5.71 $12,516 - $39,267
-6,877 Reduced 3.57%
185,534 $343,000
Q2 2021

Aug 12, 2021

BUY
$5.22 - $7.33 $1 Million - $1.41 Million
192,411 New
192,411 $1.11 Million

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.